I'll try to make a MGT vs SRN comparison in the next day or so - suspect there's an imbalance here and SRN entry.
DW8 blew out the top and should be an entry for small funds and/or tech buyers. Pivotal month with B2B launch. I like disruptive stories pivoting into success.
On the ground in the US the stimulus passing is the hot topic. Aus went hard early, US hasn't really fired $ into hands at all. Plenty of plans to spend that cheque.
Commodities and housing at record highs, not a bad time to smell the roses as an Aus investor and buy Australian.
